Study guide
15.4 Dermatologic Conditions That Cause or Complicate Wounds
Certified Wound Specialist Physician CWSP
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the CWSP Exam
2 Chapter 1: Integumentary Anatomy & Wound Healing Biology
1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation
3 Chapter 2: Musculoskeletal & Neurologic Anatomy
2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care
4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing
3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing
5 Chapter 4: Patient Evaluation & Vascular Diagnostics
4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts
6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment
5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment
7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy
6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment
8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents
7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals
9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen
8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety
10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound
9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care
11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading
10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting
12 Chapter 11: Surgical Closure & Healing Complications
11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring
13 Chapter 12: Nutrition Therapy & Case Review
12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis
14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds
13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas
15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema
14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes
16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds
15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds
17 Chapter 16: Traumatic Wounds, Burns & Frostbite
16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite
18 Chapter 17: Surgical, Infectious & Pediatric Wounds
17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care
19 Chapter 18: Reimbursement, Regulation & Documentation
18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality
20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice
19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement
15.4 Dermatologic Conditions That Cause or Complicate Wounds
Key Takeaways Explain This Topic AI
Bullous pemphigoid causes tense blisters in older adults, sometimes triggered by DPP-4 inhibitors; perilesional direct immunofluorescence shows linear IgG and C3 along the basement membrane, and potent topical corticosteroids are first-line.
Pemphigus vulgaris causes fragile flaccid blisters and painful mucosal erosions with a positive Nikolsky sign; biopsy shows intraepidermal acantholysis with intercellular IgG on direct immunofluorescence, and rituximab with corticosteroids is first-line for moderate to severe disease.
Stevens-Johnson syndrome involves less than 10% body surface area detachment, overlap 10% to 30%, and toxic epidermal necrolysis more than 30%; stop the culprit drug (such as allopurinol, anticonvulsants, or sulfonamides), estimate mortality with SCORTEN, and treat in a burn or intensive care unit.
Moisture-associated skin damage includes incontinence-associated dermatitis, intertriginous dermatitis, periwound moisture damage, and peristomal moisture damage; incontinence-associated dermatitis is diffuse with irregular edges in skin folds rather than centered over a bony prominence.
The ISTAP classification grades skin tears as type 1 (no skin loss), type 2 (partial flap loss), or type 3 (total flap loss); realign the flap when viable, use nonadherent dressings, and mark an arrow showing the direction of removal.
Last updated: September 2026
15.4 Dermatologic Conditions That Cause or Complicate Wounds
Core Clinical Principle: Many "wounds" are skin diseases, and many skin diseases complicate wounds. Recognizing blistering disorders, drug reactions, moisture damage, skin tears, and inflammatory skin conditions prevents misclassification (such as calling incontinence dermatitis a pressure injury) and leads to the right biopsy and treatment.
The CWSP outline lists dermatological wounds under Etiological Considerations. Contact dermatitis and scarring are covered with complications, and pyoderma gangrenosum and vasculitis with inflammatory ulcers.
Autoimmune Blistering Diseases
Feature Bullous Pemphigoid Pemphigus Vulgaris
Typical patient Older adults, often over 70; associated with neurologic disease and drugs such as DPP-4 inhibitors (gliptins) Middle-aged adults
Blisters Tense , on red or normal skin; intense itch; may start as hives Flaccid , fragile, rupture easily into painful erosions
- Mucosa Uncommon Almost always involved (oral erosions)
- Nikolsky sign Negative Positive
- Level of split Subepidermal Intraepidermal (suprabasal acantholysis)
- Target antigens BP180 and BP230 (hemidesmosome) Desmoglein 3, with or without desmoglein 1
Direct immunofluorescence Linear IgG and C3 along the basement membrane Intercellular IgG and C3 ("chicken-wire" pattern)
Treatment Potent topical corticosteroids (clobetasol), doxycycline, systemic steroids or steroid-sparing agents; dupilumab is FDA-approved for adults Rituximab plus systemic corticosteroids for moderate to severe disease
Biopsy technique: Take one biopsy from the edge of a fresh blister for routine histology and a second from perilesional intact skin in Michel's medium or saline for direct immunofluorescence. Serum antibody tests (such as BP180 and desmoglein ELISA) support the diagnosis.
Wound care: Leave small intact blisters in place, drain large tense blisters while keeping the roof as a biologic dressing, use nonadherent silicone or petrolatum dressings, avoid adhesives, and watch for infection in patients on immunosuppression.
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Definition by detached body surface area: SJS less than 10%, SJS/TEN overlap 10% to 30%, TEN more than 30%.
Presentation: Fever and flu-like prodrome, painful dusky macules and atypical target lesions, epidermal sloughing, and mucosal involvement (eyes, mouth, genitals), usually 4 days to 4 weeks after starting a drug.
Common culprits: Allopurinol, carbamazepine, lamotrigine, phenytoin, sulfonamide antibiotics, nevirapine, and oxicam NSAIDs. HLA-B*15:02 testing is recommended before carbamazepine in patients of certain Asian ancestries.
SCORTEN (one point each): Age 40 or older, malignancy, heart rate 120 or more, detachment above 10% on day 1, BUN above 28 mg/dL, glucose above 252 mg/dL, and bicarbonate below 20 mEq/L; higher scores predict higher mortality.
Care: Stop the culprit drug immediately, admit to a burn or intensive care unit, provide fluids, nutrition, pain control, eye care, and nonadherent dressings, avoid sulfonamide-containing products such as silver sulfadiazine, and monitor for sepsis.
Moisture-Associated Skin Damage (MASD)
MASD includes four forms: incontinence-associated dermatitis (IAD) , intertriginous dermatitis (ITD) , periwound moisture-associated dermatitis , and peristomal moisture-associated dermatitis .
- Feature Incontinence-Associated Dermatitis Pressure Injury
- Cause Urine or stool on skin Pressure or shear over bone or under a device
Location Perineum, buttocks, groin, skin folds; may extend down thighs Over bony prominences (sacrum, coccyx, heels) or device sites
Shape and edges Diffuse, irregular, poorly defined, mirror-image "kissing" lesions Usually a single, more defined shape
Depth Partial thickness; no necrosis Can involve necrosis, slough, or deep tissue
Management Gentle pH-balanced cleanser, skin protectant, containment of incontinence, treat Candida Pressure redistribution and staged wound care
Intertrigo occurs where skin touches skin; treat by drying and separating folds with moisture-wicking textiles, and add antifungal therapy for candidiasis (bright red with satellite papules and pustules). Erythrasma , a bacterial intertrigo, glows coral red under a Wood's lamp.
Skin Tears
Skin tears are traumatic wounds from shear, friction, or blunt force that separate skin layers, most common on the arms and legs of older adults.
- ISTAP Type Description
- Type 1 No skin loss: a linear or flap tear in which the flap can cover the wound bed
- Type 2 Partial flap loss: the flap cannot cover the whole wound bed
- Type 3 Total flap loss: the entire wound bed is exposed
Management: Control bleeding, gently cleanse, realign a viable flap with a moistened cotton-tipped applicator or gloved finger, apply a nonadherent silicone contact layer or foam, avoid adhesive strips on fragile skin, and draw an arrow on the dressing showing the direction of removal so the flap is not lifted. Prevent recurrence with moisturizers, padded rails, long sleeves, and careful handling.
Other Inflammatory Skin Conditions
Hidradenitis suppurativa: Painful nodules, abscesses, and sinus tracts in the axillae, groin, and buttocks. Hurley stage I has abscesses without tracts or scarring, stage II has recurrent abscesses with tracts and scarring separated by normal skin, and stage III has diffuse interconnected tracts. Treatments include antibiotics, adalimumab, secukinumab, and bimekizumab (all FDA-approved), and surgical deroofing or wide excision.
Psoriasis: New plaques can form at sites of trauma (the Koebner phenomenon ), including surgical wounds and debridement sites.
Stasis dermatitis: Itchy, scaly eczema of the lower legs from venous hypertension, often misdiagnosed as bilateral cellulitis; treat with compression, emollients, and short courses of topical steroids.
Tools: Potassium hydroxide (KOH) preparation for fungi, Wood's lamp examination, patch testing, and biopsy with direct immunofluorescence.
- Clinical Traps
- Trap 1: Staging Incontinence Dermatitis as a Pressure Injury
Diffuse, shiny, irregular erosions in the gluteal cleft and perineum of an incontinent patient are IAD. Misclassifying them inflates pressure injury rates and leads to the wrong treatment.
Trap 2: Taking the DIF Biopsy From the Blister Center
Direct immunofluorescence needs perilesional skin. A sample from an eroded blister base may be falsely negative.